Healthcare Antitrust
Clear All
Results
Showing of
Holland & Knight Health Dose: April 2, 2025
Q2 2025 Update on State Efforts to Regulate Healthcare Consolidation
Healthcare Transactions in Illinois: What Investors Should Know
A Year-End Report for Healthcare Antitrust and What to Expect Later in 2025
Annually Adjusted Hart-Scott-Rodino Thresholds and Filing Fees Take Effect Feb. 21, 2025
Podcast - Rewriting the Narrative of Private Equity in Healthcare
Understanding Chamber of Commerce v. FTC and Its Implications for the HSR Act
What's Next for Private Equity and Healthcare Investment
Antitrust Reporting Requirements for Healthcare M&A – Case Study Analysis of Federal and State Developments
Merger Challenge Hits Home (Health Care): DOJ, States Move to Prevent Merger of UnitedHealth Group and Amedisys
DOJ, States Move to Prevent Merger of Home Health Giants UnitedHealth Group and Amedisys
FTC Issues New HSR Rules Significantly Expanding Current Antitrust Reporting Obligations
5 Key Antitrust Takeaways from Holland & Knight's Panel at Nashville Healthcare Sessions 2024
Podcast - What’s Next After Gov. Gavin Newsom’s Veto in California?
The Increasing Scrutiny of Healthcare Transactions
District Court Issues Injunction Prohibiting Enforcement of FTC Non-Compete Ban
Navigating Scrutiny of Friendly Professional Corporations in California
California Court Decision Further Scrutinizes the Friendly PC Model – Now What?
Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers
"Wheels Fall Off" FTC's Latest Hospital Merger Challenge
Page 1 of 3
